This means SARS-CoV-2 infection creates an increasing trend on ALT, AST, Bilirubin.D, and Bilirubin.T and make patients’ more severe and worsen outcomes.
← all excerpts
Liver Biomarkers Assay in COVID-19 Cases: A Comparison Study between Alive and Dead Patients.
1
—
—